heart failure

Patent Wesley Crutcher with medical team members, from left, Madeline Crego, ACNP, Kashish Goel, MD, Sandip Zalawadiya, MD, Jaime Rich, Rebecca King, RN, and Aileen Balmaceda, RN.

Vanderbilt Health implants novel device to monitor atrial pressure inside patient’s heart in real time

The V-LAP device allows medical teams to monitor the pressure inside a patient’s heart in real time, allowing them to make better decisions about the patient’s medications and improving outcomes.

High-sensitivity test expected to expedite heart attack diagnosis and treatment

At Vanderbilt University Hospital, there are approximately 75,000 adult emergency department visits a year, and approximately 20% of all ED patients receive a cardiac troponin test as part of their initial evaluation. The new cardiac troponin test is more precise and provides results faster.

VUMC participating in clinical trial of novel heart failure treatment  

Patients with a form of heart failure called HFpEF may breathe normally at rest but quickly become breathless with physical activity. The study will test an atrial shunt to relieve high pressure in the heart.

Advance in the treatment of acute heart failure identified

A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.

Vanderbilt Heart and Vascular Institute patient Tony Conaway with his wife, Kim.

100th patient receives ambulatory heart failure device

New implantable device helps heart failure patients monitor crucial health indicators remotely, reducing the need for hospital visits.

BMI genetics influence heart function

Vanderbilt researchers have discovered that a genetic predisposition to elevated body mass index increases the risk of diastolic dysfunction — a cardiac condition that can lead to heart failure.

1 2 3